Original Research

Published on 15 Dec 2021

Cang-Ai Volatile Oil Ameliorates Depressive Behavior Induced by Chronic Stress Through IDO-Mediated Tryptophan Degradation Pathway

in Psychopharmacology

Kailing Zhang
Na Lei
Meng Li
Jijun Li
Caijun Li
Yue Shen
Peixin Guo
Lei Xiong
Yuhuan Xie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.791991

4,187 views
13 citations

Mini Review

Published on 14 Dec 2021

Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System

in Psychopharmacology

Heinz Grunze
Réka Csehi
Christoph Born
Ágota Barabássy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.803208

12,584 views
11 citations

Review

Published on 14 Dec 2021

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials

in Psychopharmacology

André Do
Kamyar Keramatian
Ayal Schaffer
Lakshmi Yatham

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.769897

18,721 views
10 citations

Review

Published on 13 Dec 2021

1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

in Psychopharmacology

Sylvana Vilca-Melendez
Malin V. Uthaug
Julian L. Griffin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.742856

6,554 views
2 citations

Mini Review

Published on 07 Dec 2021

Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation

in Psychopharmacology

Veronica B. Searles Quick
Ellen D. Herbst
Raj K. Kalapatapu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.750686

9,385 views
1 citation

Original Research

Published on 06 Dec 2021

Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics

in Psychopharmacology

Anna Levy
Wissam El-Hage
Djamila Bennabi
Etienne Allauze
Alexandra Bouvard
Vincent Camus
Philippe Courtet
Jean-Michel Dorey
Bruno Etain
Guillaume Fond

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.795666

3,443 views
6 citations

Original Research

Published on 03 Dec 2021

Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population

in Psychopharmacology

Anum Muzaffar
Sami Ullah
Fazal Subhan
Zahid Nazar
Syed Mehdi Hussain
Fazli Khuda
Abuzar Khan
Ameer Khusro
Muhammad Umar Khayam Sahibzada
Sarah Albogami

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.730388

39,969 views
3 citations

Original Research

Published on 03 Dec 2021

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression

in Psychopharmacology

Wei Zheng
Li-Mei Gu
Yan-Ling Zhou
Cheng-Yu Wang
Xiao-Feng Lan
Bin Zhang
Hai-Shan Shi
Dan-Feng Wang
Yu-Ping Ning

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.780975

2,162 views
7 citations

Original Research

Published on 29 Nov 2021

Nx4 Reduced Susceptibility to Distraction in an Attention Modulation Task

in Psychopharmacology

Kathrin Mayer
Marina Krylova
Sarah Alizadeh
Hamidreza Jamalabadi
Johan van der Meer
Johannes C. Vester
Britta Naschold
Myron Schultz
Martin Walter

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.746215

4,381 views
9 citations

Methods

Published on 24 Nov 2021

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews

in Psychopharmacology

Xenia M. Hart
Luzie Eichentopf
Xenija Lense
Thomas Riemer
Katja Wesner
Christoph Hiemke
Gerhard Gründer

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.787043

5,266 views
20 citations

Hypothesis and Theory

Published on 24 Nov 2021

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression

in Psychopharmacology

Sherry-Anne Muscat
Glenn Hartelius
Courtenay Richards Crouch
Kevin W. Morin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.710338

20,632 views
26 citations

Original Research

Published on 24 Nov 2021

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective

in Psychopharmacology

Stephan Hjorth

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.760181

10,308 views
16 citations

Review

Published on 23 Nov 2021

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine

in Psychopharmacology

Borjanka Batinic
Ivan Ristic
Milica Zugic
David S. Baldwin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.784370

8,459 views
8 citations

Original Research

Published on 23 Nov 2021

Cannabis Use, Schizotypy and Kamin Blocking Performance

in Psychopharmacology

Christopher Dawes
Andrea Bickerdike
Cian O'Neill
Sarah Carneiro Pereira
John L. Waddington
Paula M. Moran
Colm M. P. O'Tuathaigh

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.633476

3,098 views
3 citations

Case Report

Published on 22 Nov 2021

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms

in Psychopharmacology

Octavian Vasiliu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.786171

4,521 views
14 citations

Original Research

Published on 18 Nov 2021

A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring

in Psychopharmacology

Wei Guo
Ze Yu
Ya Gao
Xiaoqian Lan
Yannan Zang
Peng Yu
Zeyuan Wang
Wenzhuo Sun
Xin Hao
Fei Gao

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.711868

3,839 views
13 citations

Navigation group

Articles

Cang-Ai Volatile Oil Ameliorates Depressive Behavior Induced by Chronic Stress Through IDO-Mediated Tryptophan Degradation Pathway

Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials

1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation

Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics

Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression

Nx4 Reduced Susceptibility to Distraction in an Attention Modulation Task

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine

Cannabis Use, Schizotypy and Kamin Blocking Performance

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms

A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring